contentsubscribe

All issues online, mobile friendly. Works on mobile, tablets & desktop.

NLS

June 24, 2017

Published: June 24, 2017

Combotope Therapeutics enters into collaboration with Boehringer Ingelheim

The partnership will leverage Combotope’s SMART-Phage platform to generate highly tumor-selective antibodies for next-generation cancer therapies.

Biotech Business – June 23, 2026

CHOSA Oncology establishes US presence in Boston

CHOSA Oncology has established a business presence in Boston, Massachusetts, marking an important strategic step in the company’s US commercialization for Platin-DRP.

MedTech Business – June 23, 2026

Stratipath has received CE marking under the In Vitro Diagnostic Regulation

Stratipath Breast has received CE marking under the In Vitro Diagnostic Regulation (IVDR, EU 2017/746), the EU’s most stringent regulatory framework for in vitro diagnostic medical devices.

Clinical Trials – June 23, 2026

Elicera receives positive feedback from Swedish MPA on clinical study in Grade IV Glioma

Elicera Therapeutics held a scientific advice meeting with the Swedish Medical Products Agency (MPA) regarding the planned first-in-human clinical study of ELC-401, the company’s iTANK-armed CAR T-cell candidate targeting IL13Ra2 in grade IV glioma.